{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T10:40:51Z","timestamp":1777977651095,"version":"3.51.4"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2017,3,4]],"date-time":"2017-03-04T00:00:00Z","timestamp":1488585600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1007\/s00415-017-8444-9","type":"journal-article","created":{"date-parts":[[2017,3,4]],"date-time":"2017-03-04T06:46:31Z","timestamp":1488609991000},"page":"891-897","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":96,"title":["Long-term outcomes of refractory neurosarcoidosis treated with infliximab"],"prefix":"10.1007","volume":"264","author":[{"given":"Fleur","family":"Cohen Aubart","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diane","family":"Bouvry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Damien","family":"Galanaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Dehais","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillaume","family":"Mathey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitri","family":"Psimaras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julien","family":"Haroche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corinne","family":"Pottier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"Hie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexis","family":"Mathian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herv\u00e9","family":"Devilliers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hilario","family":"Nunes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominique","family":"Valeyre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahir","family":"Amoura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,3,4]]},"reference":[{"key":"8444_CR1","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1164\/rccm.200603-402OC","volume":"174","author":"RP Baughman","year":"2006","unstructured":"Baughman RP, Drent M, Kavuru M, Judson MA, Costabel U, du Bois R, Albera C, Brutsche M, Davis G, Donohue JF, Muller-Quernheim J, Schlenker-Herceg R, Flavin S, Lo KH, Oemar B, Barnathan ES, Sarcoidosis I (2006) Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement. Am J Respir Crit Care Med 174:795\u2013802","journal-title":"Am J Respir Crit Care Med"},{"key":"8444_CR2","first-page":"60","volume":"17","author":"RP Baughman","year":"2000","unstructured":"Baughman RP, Winget DB, Lower EE (2000) Methotrexate is steroid sparing in acute sarcoidosis: results of a double blind, randomized trial. Sarcoidosis Vasc Diffus Lung Dis Off J Wasog\/World Assoc Sarcoidosis Other Granul Disord 17:60\u201366","journal-title":"Sarcoidosis Vasc Diffus Lung Dis Off J Wasog\/World Assoc Sarcoidosis Other Granul Disord"},{"key":"8444_CR3","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.amjmed.2004.03.013","volume":"117","author":"JD Carter","year":"2004","unstructured":"Carter JD, Valeriano J, Vasey FB, Bognar B (2004) Refractory neurosarcoidosis: a dramatic response to infliximab. Am J Med 117:277\u2013279","journal-title":"Am J Med"},{"key":"8444_CR4","doi-asserted-by":"publisher","first-page":"207","DOI":"10.4103\/0972-2327.70874","volume":"13","author":"S Chintamaneni","year":"2010","unstructured":"Chintamaneni S, Patel AM, Pegram SB, Patel H, Roppelt H (2010) Dramatic response to infliximab in refractory neurosarcoidosis. Ann Indian Acad Neurol 13:207\u2013210","journal-title":"Ann Indian Acad Neurol"},{"key":"8444_CR5","doi-asserted-by":"publisher","unstructured":"Cinetto F, Agostini C (2016) Advances in understanding the immunopathology of sarcoidosis and implications on therapy. Expert Rev Clin Immunol 12(9):973\u2013988","DOI":"10.1080\/1744666X.2016.1181541"},{"key":"8444_CR6","doi-asserted-by":"publisher","first-page":"336","DOI":"10.7326\/0003-4819-87-3-336","volume":"87","author":"P Delaney","year":"1977","unstructured":"Delaney P (1977) Neurologic manifestations in sarcoidosis: review of the literature, with a report of 23 cases. Ann Intern Med 87:336\u2013345","journal-title":"Ann Intern Med"},{"key":"8444_CR7","first-page":"91","volume":"31","author":"M Drent","year":"2014","unstructured":"Drent M, Cremers JP, Jansen TL, Baughman RP (2014) Practical eminence and experience-based recommendations for use of TNF-alpha inhibitors in sarcoidosis. Sarcoidosis Vasc Diffus Lung Dis Off J Wasog\/World Assoc Sarcoidosis Other Granul Disord 31:91\u2013107","journal-title":"Sarcoidosis Vasc Diffus Lung Dis Off J Wasog\/World Assoc Sarcoidosis Other Granul Disord"},{"key":"8444_CR8","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1212\/WNL.57.5.927","volume":"57","author":"D Ferriby","year":"2001","unstructured":"Ferriby D, de Seze J, Stojkovic T, Hachulla E, Wallaert B, Destee A, Hatron PY, Vermersch P (2001) Long-term follow-up of neurosarcoidosis. Neurology 57:927\u2013929","journal-title":"Neurology"},{"key":"8444_CR9","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1183\/09031936.00051907","volume":"31","author":"MA Judson","year":"2008","unstructured":"Judson MA, Baughman RP, Costabel U, Flavin S, Lo KH, Kavuru MS, Drent M, Centocor TSI (2008) Efficacy of infliximab in extrapulmonary sarcoidosis: results from a randomised trial. Euro Respir J 31:1189\u20131196","journal-title":"Euro Respir J"},{"key":"8444_CR10","first-page":"112","volume":"7","author":"C Kobylecki","year":"2007","unstructured":"Kobylecki C, Shaunak S (2007) Refractory neurosarcoidosis responsive to infliximab. Pract Neurol 7:112\u2013115","journal-title":"Pract Neurol"},{"key":"8444_CR11","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1097\/WNF.0000000000000047","volume":"37","author":"AO Lorentzen","year":"2014","unstructured":"Lorentzen AO, Sveberg L, Midtvedt O, Kerty E, Heuser K (2014) Overnight response to infliximab in neurosarcoidosis: a case report and review of infliximab treatment practice. Clin Neuropharmacol 37:142\u2013148","journal-title":"Clin Neuropharmacol"},{"key":"8444_CR12","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1001\/archinte.1997.00440370104011","volume":"157","author":"EE Lower","year":"1997","unstructured":"Lower EE, Broderick JP, Brott TG, Baughman RP (1997) Diagnosis and management of neurological sarcoidosis. Arch Intern Med 157:1864\u20131868","journal-title":"Arch Intern Med"},{"key":"8444_CR13","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1212\/WNL.37.3.461","volume":"37","author":"RA Luke","year":"1987","unstructured":"Luke RA, Stern BJ, Krumholz A, Johns CJ (1987) Neurosarcoidosis: the long-term clinical course. Neurology 37:461\u2013463","journal-title":"Neurology"},{"key":"8444_CR14","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1212\/01.wnl.0000341278.26993.22","volume":"72","author":"M Moravan","year":"2009","unstructured":"Moravan M, Segal BM (2009) Treatment of CNS sarcoidosis with infliximab and mycophenolate mofetil. Neurology 72:337\u2013340","journal-title":"Neurology"},{"key":"8444_CR15","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1212\/WNL.60.7.1220-a","volume":"60","author":"Z Morcos","year":"2003","unstructured":"Morcos Z (2003) Refractory neurosarcoidosis responding to infliximab. Neurology 60:1220\u20131221","journal-title":"Neurology"},{"key":"8444_CR16","first-page":"657","volume":"108","author":"MW O\u2019Reilly","year":"2015","unstructured":"O\u2019Reilly MW, Sexton DJ, Dennedy MC, Counihan TJ, Finucane FM, O\u2019Brien T, O\u2019Regan AW (2015) Radiological remission and recovery of thirst appreciation after infliximab therapy in adipsic diabetes insipidus secondary to neurosarcoidosis. QJM Mon J Assoc Phys 108:657\u2013659","journal-title":"QJM Mon J Assoc Phys"},{"key":"8444_CR17","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1111\/j.1445-5994.2011.02457.x","volume":"41","author":"J Pereira","year":"2011","unstructured":"Pereira J, Anderson NE, McAuley D, Bergin P, Kilfoyle D, Fink J (2011) Medically refractory neurosarcoidosis treated with infliximab. Intern Med J 41:354\u2013357","journal-title":"Intern Med J"},{"key":"8444_CR18","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1212\/01.WNL.0000034766.13282.33","volume":"59","author":"JA Pettersen","year":"2002","unstructured":"Pettersen JA, Zochodne DW, Bell RB, Martin L, Hill MD (2002) Refractory neurosarcoidosis responding to infliximab. Neurology 59:1660\u20131661","journal-title":"Neurology"},{"key":"8444_CR19","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1136\/jnnp.2008.149989","volume":"81","author":"E Santos","year":"2010","unstructured":"Santos E, Shaunak S, Renowden S, Scolding NJ (2010) Treatment of refractory neurosarcoidosis with Infliximab. J Neurol Neurosurg Psychiatry 81:241\u2013246","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"8444_CR20","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1007\/s00415-004-0432-1","volume":"251","author":"M Sollberger","year":"2004","unstructured":"Sollberger M, Fluri F, Baumann T, Sonnet S, Tamm M, Steck AJ, Brutsche M (2004) Successful treatment of steroid-refractory neurosarcoidosis with infliximab. J Neurol 251:760\u2013761","journal-title":"J Neurol"},{"key":"8444_CR21","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/S0140-6736(13)60680-7","volume":"383","author":"D Valeyre","year":"2014","unstructured":"Valeyre D, Prasse A, Nunes H, Uzunhan Y, Brillet PY, Muller-Quernheim J (2014) Sarcoidosis. Lancet 383:1155\u20131167","journal-title":"Lancet"},{"key":"8444_CR22","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1183\/09031936.00055213","volume":"43","author":"AD Vorselaars","year":"2014","unstructured":"Vorselaars AD, Verwoerd A, van Moorsel CH, Keijsers RG, Rijkers GT, Grutters JC (2014) Prediction of relapse after discontinuation of infliximab therapy in severe sarcoidosis. Euro Respir J 43:602\u2013609","journal-title":"Euro Respir J"},{"key":"8444_CR23","first-page":"103","volume":"92","author":"JP Zajicek","year":"1999","unstructured":"Zajicek JP, Scolding NJ, Foster O, Rovaris M, Evanson J, Moseley IF, Scadding JW, Thompson EJ, Chamoun V, Miller DH, McDonald WI, Mitchell D (1999) Central nervous system sarcoidosis\u2013diagnosis and management. QJM Month J Assoc Phys 92:103\u2013117","journal-title":"QJM Month J Assoc Phys"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-017-8444-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-017-8444-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-017-8444-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,2]],"date-time":"2017-05-02T14:11:06Z","timestamp":1493734266000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-017-8444-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,4]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["8444"],"URL":"https:\/\/doi.org\/10.1007\/s00415-017-8444-9","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,4]]}}}